A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
Public ClinicalTrials.gov record NCT05909904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase 2, Open-Label, Multi-Arm Study of Tislelizumab in Combination With Investigational Agents as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Study identification
- NCT ID
- NCT05909904
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- BeiGene
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Interventions
- BGB-A425 Drug
- LBL-007 Drug
- Tislelizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 20, 2023
- Primary completion
- Jun 16, 2025
- Completion
- May 27, 2026
- Last update posted
- Oct 6, 2025
2023 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valkyrie Clinical Trials | Los Angeles | California | 90067 | — |
| Stanford Medicine | Stanford | California | 94305 | — |
| Rocky Mountain Cancer Centers, Llp(Us Oncology Research) | Lone Tree | Colorado | 80124 | — |
| Florida Cancer Specialist Research Institute Lake Nona | Orlando | Florida | 32827 | — |
| Florida Cancer Specialist Research Institute Panhandle | Tallahassee | Florida | 32308 | — |
| University of Kentucky Markey Cancer Center | Lexington | Kentucky | 40536 | — |
| Oncology and Hematology Associates of Southwest Virginia, Inc (Us Oncology Research) | Blacksburg | Virginia | 24060 | — |
| Cancer Care Northwest | Spokane Valley | Washington | 99216 | — |
| Northwest Cancer Specialist, Pc(Us Oncology Research) | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05909904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2025 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05909904 live on ClinicalTrials.gov.